[1]
“DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA”, Mediterr J Hematol Infect Dis, vol. 10, no. 1, p. e2018066, Nov. 2018, doi: 10.4084/mjhid.2018.066.